---
reference_id: "PMID:23164669"
title: Drug-induced lupus erythematosus.
authors:
- Pretel M
- Marquès L
- España A
journal: Actas Dermosifiliogr
year: '2014'
doi: 10.1016/j.ad.2012.09.007
content_type: abstract_only
---

# Drug-induced lupus erythematosus.
**Authors:** Pretel M, Marquès L, España A
**Journal:** Actas Dermosifiliogr (2014)
**DOI:** [10.1016/j.ad.2012.09.007](https://doi.org/10.1016/j.ad.2012.09.007)

## Content

1. Actas Dermosifiliogr. 2014 Jan-Feb;105(1):18-30. doi:
10.1016/j.ad.2012.09.007.  Epub 2012 Nov 17.

Drug-induced lupus erythematosus.

[Article in English, Spanish]

Pretel M(1), Marquès L(2), España A(2).

Author information:
(1)Departamento de Dermatología, Clínica Universidad de Navarra, Facultad de 
Medicina, Universidad de Navarra, Pamplona, España. Electronic address: 
mpretel@unav.es.
(2)Departamento de Dermatología, Clínica Universidad de Navarra, Facultad de 
Medicina, Universidad de Navarra, Pamplona, España.

Drug-induced lupus erythematosus (DILE) refers to a condition whose clinical, 
histological, and immunological features are similar to those seen in idiopathic 
lupus erythematosus but that occurs when certain drugs are taken and resolves 
after their withdrawal. Over 90 drugs have been linked to DILE to date and the 
list is growing. Like idiopathic lupus erythematosus, DILE has systemic, 
subacute cutaneous, and chronic cutaneous forms. A correct diagnosis is very 
important, as this condition usually resolves after withdrawal of the offending 
drug.

Copyright © 2012 Elsevier España, S.L. and AEDV. All rights reserved.

DOI: 10.1016/j.ad.2012.09.007
PMID: 23164669 [Indexed for MEDLINE]